INTRODUCTION

These educational Mini Modules will explain important considerations for managing patients with HIV and hepatitis co-infection.

Release Date: December 12, 2017
Expiration Date: November 30, 2018

TARGET AUDIENCE

This activity is intended for physicians, physician assistants, nurse practitioners, and nurses who treat/manage patients with HIV and/or viral hepatitis.

LEARNING OBJECTIVES

Upon completion of this enduring material, participants should be able to:

METHOD OF PARTICIPATION / HOW TO RECEIVE CREDIT

• There are no fees for participating in and receiving credit for this activity.
• Review the activity objectives and CME/CE information.
• Review all modules associated with this course
• Successfully complete the post-test (80% accuracy)
• Complete the CME/CE evaluation
• The estimated time to complete this activity is hour.
• Upon successful completion of the initial evaluation, your CME/CNE certificate will be available to print for your records.

JOINT PROVIDERSHIP

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Nebraska Medical Center, Center for Continuing Education, the University of Nebraska Medical Center College of Nursing Continuing Nursing Education, and Practice Point Communications.

ACCREDITATION STATEMENTS

Participation in the entire knowledge-based activity is required to obtain a certificate. This activity is being presented without bias and with commercial support.

RESOLUTION OF CONFLICT OF INTEREST

In accordance with the ACCME Standards for Commercial Support of CME, the University of Nebraska Medical Center, Center for Continuing Education, College of Nursing Continuing Nursing Education, and Practice Point Communications will implement mechanisms, prior to the planning and implementation of this CME/CE activity, to identify and resolve conflicts of interest for all individuals in a position to control content of this CME/CE activity.

DISCLOSURE

All planners and faculty participating in continuing education activities provided by the University of Nebraska Medical Center, Center for Continuing Education, and University of Nebraska Medical Center, College of Nursing Continuing Nursing Education are expected to disclose to the audience any support or relationship(s) with providers of commercial products and/or devices discussed in this activity and/or with any commercial supporters of the activity. A commercial interest is any entity producing, marketing, re-selling, or distributing healthcare goods or services consumed by, or used on, patients. Disclosure of these commitments and/or relationships is included in activity materials so that participants in the activity may formulate their own judgments in interpreting its content and evaluating its recommendations. In addition, all faculty are expected to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in their presentation. The planners and faculty have been advised that this activity must be free from commercial bias, and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

All materials are included with the permission of the authors. The opinions expressed are those of the authors and are not to be construed as those of the University of Nebraska Medical Center, Center for Continuing Education or the University of Nebraska Medical Center, College of Nursing Continuing Nursing Education.

The following indicates the disclosure declaration information and the nature of those commercial relationships.

DISCLOSURES

The speakers and planning committee members listed below have stated they have no significant relationships to disclose.
Heidi Keeler, PhD, RN
Sarah Bares, MD
Uriel Sandkovsky, MD
Brenda Ram, CMP, CHCP
Kristin Weitzel, Pharm.D., FAPhA
Chris Fleming
Kelly McCulloch

The following speakers and/or planners have stated that they have the following financial relationship(s) and they have agreed to see that all information they planned and/or present is done so fairly and without bias:

FACULTY DISCLOSURES

Kenneth Sherman, MD, PhD
Employment (includes retainer): None
Industry-Funded Research/Investigator: AbbVie, Bristol-Myers Squibb, Gilead Sciences, Innovio, Intercept, MedImmune/Astra Zeneca, Merck & Co.
Consultant: MedImmune/Astra Zeneca, Merck & Co.
Speakers Bureau, Faculty, Peer Reviewer: None
Advisory Committee/Board: None
Stock/Ownership: None
Patent holder: None
Other: MedPace (DSMB Member)
Plan to discuss investigational/off-label uses of drugs or devices? (Y/N):

DISCLAIMER

The University of Nebraska Medical Center, Center for Continuing Education, College of Nursing Continuing Nursing Education, and Practice Point Communications present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The University of Nebraska Medical Center, Center for Continuing Education, College of Nursing Continuing Nursing Education, Practice Point Communications, and Gilead Sciences Medical Affairs assume no liability for the information herein. Accredited status as a continuing nursing education provider refers only to the University of Nebraska Medical Center College of Nursing Continuing Nursing Education continuing education activities, and does not imply UNMC or American Nurses Credentialing Center Commission on Accreditation endorsement of any commercial supporters.

PRIVACY POLICY

The University of Nebraska Medical Center, Center for Continuing Education, College of Nursing Continuing Nursing Education, and Practice Point Communications protects the privacy of personal and other information regarding participants and educational collaborators. The University of Nebraska Medical Center, Center for Continuing Education, College of Nursing Continuing Nursing Education, and Practice Point Communications will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the ACCME or ANCC.

The University of Nebraska Medical Center, Center for Continuing Education, College of Nursing Continuing Nursing Education, and Practice Point Communications maintain physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse or alteration of information that we have collected from you.

COPYRIGHT INFORMATION

Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software (“Materials”) found on the site subject to the following terms, conditions, and exceptions:

The Materials are to be used solely for personal, noncommercial, informational and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.

Materials may not be published, uploaded, posted, transmitted (other than as set forth herein), without prior written permission.

HARDWARE/SOFTWARE REQUIREMENTS

• Hardware: A minimum of 512MB of RAM and a Pentium IV CPU for Intel-based hardware & PowerPC G4 or above for MAC.
• Graphics/Monitor: A color monitor capable of a minimum of 1024 x 768 pixel resolution.
• Network: An Internet connection with 1Mbps available download & 256kbps bandwidth.

• Windows 7 or above running Internet Explorer 10 or above.
• MAC OSX 10.5 (Leopard) or above running Safari 6 or above, or any version of Chrome, Firefox or Opera published in the last two years.
• A recent version of a Linux distribution or FreeBSD running Chrome v13, Opera 11.5, Firefox 5.0.1, or Epiphany 3.0.4 or above.

• Any Apple iPad or iPad Mini running iOS 7.1 or above.
• Android tablets such as the Kindle Fire or Samsung Galaxy S.

COMMERCIAL SUPPORT ACKNOWLEDGMENT